[1]
M. I. Anand, “SGLT2 INHIBITORS DECREASE CARDIOVASCULAR DEATH AND HEART FAILURE HOSPITALIZATIONS: A SYSTEMATIC REVIEW ”, JARMHS, vol. 8, no. 11, pp. 7–13, Nov. 2022, Accessed: Sep. 19, 2024. [Online]. Available: http://jarmhs.com/MHS/index.php/mhs/article/view/74